CI&T Q3 2026 slides: revenue beats, margin gains, but EPS miss hits stock

CI&T (NYSE:CINT) reported Q3 2026 revenue of $146.3M, beating estimates, but EPS of $0.09 missed expectations. Revenue grew 14.9% YoY, with margin expansion to 36.6%. Shares fell 6.9% in after-hours trading. The company raised full-year revenue guidance but warned of macroeconomic uncertainty.

Original reporting
Published Nov 11, 2026, 10:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 10:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CINT
Bearish
high confidence
Mentioned
$CINT
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CINTBearishMed
01

Why it matters

The earnings miss and guidance uncertainty triggered a notable after‑hours sell‑off, highlighting sensitivity to EPS expectations.

02

Market read

First‑time earnings disclosure with modest scale; impacts CINT and potentially other AI service stocks.

03

What to watch

Value‑based pricing mix and AI‑builder productivity gains could sustain longer‑term upside.

Relevance 7/10Novelty 8/10Timing: after‑hours reaction today

Background

CI&T is a Brazilian digital transformation firm transitioning to an AI‑first model, reporting its Q3 2026 results.

Company-level read

Ticker impact

$CINTBearishHigh confidence
Context

Q3 2026 results showed revenue beat but EPS miss, triggering a 6.9% after‑hours drop.

Expected impact

likely downward pressure as investors price in the EPS shortfall

Evidence & confidence

The miss of $0.09 vs $0.10 consensus and weaker guidance drove a sharp after‑hours sell‑off.

Market effects

AI‑focused digital transformation firms may see heightened scrutiny on margin guidance.

Brazilian companies could feel pressure from FX‑related margin compression.

Limited; primarily affects CINT and peers in the AI services niche.

Counterpoint

Margin expansion and revenue growth remain strong; the EPS miss may be a short‑term overreaction.

Key entities

  • CI&T

    Brazilian digital transformation and AI services provider (NYSE:CINT).

Related articles

$CINTMed

CI&T Inc (CINT) (Q3 2026) Earnings Call Highlights: Record Revenue and AI-Driven

CI&T Inc (CINT) reported Q3 2026 revenue growth of 14.9% YoY, but adjusted EBITDA declined 3.9% due to FX and payroll tax headwinds. Q4 guidance is $142.3M-$152.0M, with deceleration due to macro uncertainty. Gross margin expanded sequentially due to AI-driven productivity and value-based models, but organic growth slowed. The pipeline is up 50% YoY, with 70% from existing clients. AI partnerships and value-based models are expected to drive 2027 growth.

$CINTLow

What CI&T (CINT) Said on Its Q3 Earnings Call

CI&T (CINT) reported Q3 adjusted EBITDA fell 3.9% YoY due to currency effects, but rose 3.4% on a currency-neutral basis to $24.3M. Revenue from non-top-10 clients grew 17.1% YoY, outpacing top clients' 12.2% growth. Adjusted profit increased 2% to $11.5M. The company forecasted Q4 revenue of $142.3M-$152.0M and raised its 2026 revenue outlook to $568M-$578M.

$CINTMedAI 8/10

CI&T (CINT) Q2 2026 Earnings Call Transcript

CI&T (CINT) reported Q2 2026 revenue of $142.8M, up 21.9% YoY, exceeding guidance. Full-year revenue guidance raised to $566M-$578M. Adjusted EBITDA was $19M with a 13.3% margin. Sales pipeline expanded 40% YoY, driven by AI demand. Financial services and tech/telecom verticals grew 36% and 68% YoY, respectively. Consumer goods revenue declined 9% YoY. Management highlighted investments in AI and value-based pricing models.

MedAI 8/10

CI&T Inc Q2 2026 Earnings Call Summary

CI&T Inc reported Q2 2026 results and said record revenue growth reflects a shift to AI deployments and value-based pricing. Adjusted gross margin rose to 32.4%. Full-year revenue guidance was raised to $566 million to $578 million, with adjusted EBITDA margin at 15% to 17% amid FX headwinds and planned AI investments.

$SGPMedAI 8/10

SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

SpyGlass Pharma, Inc. (SGP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates • Acquired Advanced Vision Science, Inc. (AVS), securing scalable commercial intraocular lens (IOL) manufacturing capacity for its Phase 3 lead product candidate the Bimatopro

$ONDSHighAI 8/10

Ondas Posts Record Q3 2026 Revenue of $167.5 Million on Strong Bookings and Backlog Growth; Raises Full-Year Outlook

Ondas Inc. (ONDS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ondas Posts Record Q3 2026 Revenue of $167.5 Million on Strong Bookings and Backlog Growth; Raises Full-Year Outlook Record Q3 revenue of $167.5 million, up 100% sequentially and more than 16-fold year over year; pro forma organic revenue grew 64% year-over-year Capt